Browsing by Yonsei Author

라선영 [Rha, Sun Young]
Department :
College of Medicine : Dept. of Internal Medicine
(Yonsei Health Research Network)
Issue DateTitleAuthor(s)
2017 Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia 김지현, 정현철, 정희철, 형우진, 안중배, 전홍재, 김현기, 노성훈, 라선영, 박소희
2017 Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab 김승섭, 김현기, 김효송, 라선영, 이충근, 임준석, 정민규, 정현철, 허수진, 박소희
2017 Prevalence and prognostic implications of psychological distress in patients with gastric cancer 김건민, 김경란, 김혜련, 노성훈, 라선영, 정현철, 송수경
2017 Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. 강원준, 최영득, 라선영, 윤미진, 조응혁
2017 Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia 김지현, 김현기, 노성훈, 라선영, 안중배, 전홍재, 정현철, 정희철, 형우진, 박소희
2017 Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma 김경식, 김민환, 김효송, 라선영, 최영득
2017 ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition 김태수, 라선영, 안중배, 정현철, 정희철
2016 Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy 김형일, 김효송, 노성훈, 라선영, 안지영, 이충근, 정민규, 정인경, 정재호, 정현철, 허수진, 형우진
2016 Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium 라선영
2016 Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 라선영
2016 p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer 김남규, 노재경, 라선영, 김태일, 박규현, 신상준, 안중배, 이강영
2016 PTEN Methylation Dependent Sinonasal Mucosal Melanoma 강버들, 노미령, 라선영, 박규현, 이상은, 이상희
2016 Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. 김지형, 김혜련, 노성훈, 라선영, 송수경, 송승은, 이유미, 이호선
2016 Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma. 라선영, 최영득, 정현주, 조남훈
2016 Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. 노미령, 라선영, 정기양
2016 Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites 김태수, 정현철, 김효송, 박규현, 박준용, 라선영
2016 Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience. 김경식, 김성훈, 김효송, 노성훈, 라선영, 범승훈, 서진석, 신규호, 오윤정, 이영한, 조영진, 최영득, 허혁
2016 Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients. 김윤남, 김주훈, 라선영, 임선민
2016 Prognostic implications of PIK3CA amplification in curatively resected liposarcoma 김경식, 김성훈, 라선영, 박규현, 서진석, 신규호, 안중배, 이영한, 최영득, 허혁, 김효송, 노성훈
2016 Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. 김현기, 노성훈, 라선영, 윤미진, 정민규, 정현철, 조응혁, 형우진, 정재호, 김형일, 김효송
2016 Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis 김주훈, 김태수, 라선영
2016 Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma 김경식, 김효송, 노성훈, 라선영, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁, 김성훈
2016 Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy 금웅섭, 정재호, 김현기, 정현수, 김형일, 정현철, 김효송, 최윤영, 노성훈, 형우진, 라선영, 박준철, 범승훈, 손태일, 신상준, 신성관, 이상길, 이용찬, 임준석, 정민규
2016 High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer 김남규, 라선영, 신상준, 안중배, 이강영, 정현철, 정희철
2016 Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer 김현기, 김효송, 노성훈, 라선영, 정재호
2016 A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology 김효송, 라선영
2016 Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08 김주훈, 김지형, 김효송, 라선영, 허수진
2016 Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration 금기창, 금웅섭, 김효송, 노성훈, 라선영, 이용찬, 임준석, 장지석, 형우진
2016 Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm 김현기, 김효송, 노성훈, 라선영, 이상길, 이용찬, 정재호, 허용민, 형우진
2016 Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee 김효송, 라선영
2015 PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer 김효송, 라선영, 장향란, 정민규, 정현철
2015 Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer 김형일, 김효송, 노성훈, 라선영, 박형순, 안지영, 정민규, 정재호, 정현철, 형우진
2015 Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children 김수희, 김효송, 노재경, 라선영, 신규호, 신상준, 안중배, 양우익, 유철주, 임선민, 정현철, 조용진, 한정우
2015 Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer 금기창, 금웅섭, 김미선, 라선영, 이용찬, 형우진
2015 PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity 정현철, 권우선, 김남규, 라선영, 박찬희, 신상준, 안중배, 양우익
2015 Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer 이충근, 정현철, 이강영, 이명은, 김정민, 라선영, 안중배
2015 Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with conformal bone system: a preliminary report. 라선영, 박미숙, 서진석, 이영한, 임승택, 최혜진
2015 Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series 김수희, 김효송, 라선영, 신규호, 조용진
2015 Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study 김원호, 라선영, 천재희
2015 Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation 노미령, 라선영, 이상희, 정기양
2015 Clinicopathological features and prognostic significance of HER2 expression in gastric cancer 김기향, 김현기, 김형일, 김효송, 노성훈, 라선영, 안지영, 전현정, 정민규, 정재호, 정현철, 형우진
2015 Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer 라선영
2015 Caregiving burden and the quality of life of family caregivers of cancer patients: the relationship and correlates 라선영
2015 Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer 라선영
2015 The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study 라선영
2015 Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium 라선영
2015 Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium 라선영
2015 Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas 라선영
2015 Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10 라선영, 이수현
2015 Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer 라선영
2015 Cutaneous Serratia marcescens infections in Korea: A retrospective analysis of 13 patients 라선영, 이상희, 정기양, 노미령
2015 Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine 노미령, 김혜련, 김효송, 라선영, 신상준, 안중배, 이충근, 정민규, 정현철, 최혜진, 허수진
2014 Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study 김세훈, 김효송, 노재경, 라선영, 신규호, 양우익, 이재석, 임선민, 조영진
2014 Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: Correlation with histological microvessel density 정용은, 최병욱, 허진, 홍유진, 김영진, 라선영, 심효섭, 이혜정
2014 Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study 김효송, 노재경, 라선영, 박경숙, 서진석, 신규호, 안중배, 양우익, 이영한, 조영진
2014 Ifosfamide-induced Fanconi syndrome with diabetes insipidus 강버들, 김민환, 김한상, 김효송, 라선영, 유병우, 임아영
2014 Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer 노성훈, 라선영, 신유근, 정현철, 정희철
2014 Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet Exposure 노미령, 라선영, 배정민, 오병호, 이재석, 정기양, 김지형
2014 High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients 김남규, 라선영, 신상준, 안중배, 정현철
2014 Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane 남정모, 라선영, 안중배, 양우익, 임승택, 전홍재, 정현철, 정희철, 홍민희, 강버들
2014 Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma 라선영
2014 Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case. 조성빈, 라선영
2014 Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee 김효송, 라선영
2014 Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency 김혜련, 라선영
2014 A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer. 라선영
2014 Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. 라선영
2014 First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. 라선영
2014 Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial. 라선영
2014 Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients. 라선영
2014 Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review 라선영
2014 Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials 라선영
2014 A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma. 라선영
2014 First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium. 라선영
2014 The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. 김정민, 라선영, 박승우, 신유근, 유은정, 장향란, 정현철, 정희철
2014 The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. 라선영
2014 The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium. 라선영
2014 Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. 라선영
2014 Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. 라선영
2013 Identifying genes related to radiation resistance in oral squamous cell carcinoma cell lines 김세헌, 라선영, 박행란, 조남훈, 최윤표
2013 Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent 노재경, 라선영, 신상준, 안중배, 정현철, 황지원
2013 Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer 김귀언, 김용배, 라선영, 정인혜, 정현철, 정희철
2013 Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. 라선영
2013 Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice 노미령, 라선영, 정기양, 정희철
2013 Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer 심효섭, 이지현, 강대용, 이진구, 김대준, 이창영, 김세훈, 임선민, 김주항, 정경영, 김혜련, 조병철, 라선영, 배미경
2013 Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin – A Treatment 정현철, 라선영, 유정은, 정아라
2013 Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer 라선영
2013 Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program 라선영
2013 Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis 라선영
2013 External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study 라선영
2013 Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells 김용배, 라선영, 정현철, 정희철
2013 Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study 김남규, 노재경, 라선영, 신상준, 안중배, 정현철, 차인호, 김기열
2013 Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma 라선영
2013 The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma 조병철, 홍윤경, 김주항, 김혜련, 남기창, 라선영, 안정련, 이진구
2013 Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool 남정모, 노재경, 라선영, 양우익, 이수현, 정민규, 정현철, 정희철
2013 Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer 정희철, 강버들, 김기열, 김찬, 노성훈, 라선영, 전홍재, 정현철
2013 Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum 김효송, 라선영, 박지수, 안중배, 양우익, 이영기, 임태섭, 정현철
2013 Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진
2013 Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. 김기열, 노재경, 라선영, 박찬희, 신상준, 안중배, 임선민, 정현철
2013 Changing treatment patterns in elderly patients with resectable colon cancer 정현철, 강버들, 김건민, 김남규, 김민환, 김한상, 노재경, 라선영, 신상준, 안중배
2013 Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철
2013 Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation 임준석, 형우진, 금웅섭, 노성훈, 라선영, 안지영, 윤홍인, 이용찬
2013 Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients 김효송, 라선영, 박형순, 신상준, 안중배, 이지현, 임선민, 권우선, 김혜련
2013 Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma 김효송, 라선영, 신상준, 안중배, 윤상현, 이혜정
2013 PIK3CA Mutations in Hepatocellular Carcinoma in Korea 라선영
2013 Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria 라선영
2012 Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry 안중배, 임선민, 정현철, 황지원, 노재경, 라선영, 신상준
2012 External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer 김기열, 김주훈, 김효송, 남정모, 라선영
2012 Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience. 정현철, 김남규, 김태일, 노재경, 라선영, 신상준, 안중배, 정민규, 정인경
2012 Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells. 김선정, 김용배, 김한상, 라선영, 박찬희, 안중배, 정현철, 정희철
2012 Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. 김세규, 김세훈, 김주항, 김혜련, 라선영, 심효섭, 정경영, 조병철, 홍윤경
2012 Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. 라선영
2012 Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma. 라선영
2012 Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. 이하영, 임승택, 한정우, 홍수정, 김효송, 노재경, 라선영, 신상준
2012 An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy. 라선영
2012 A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. 김건민, 김효송, 라선영, 정인경, 정현철
2012 Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. 노미령, 라선영, 정기양, 정희철
2012 A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. 라선영, 정현철
2012 A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer. 박현종, 김상운, 김성훈, 김영태, 남은지, 라선영
2012 Methylation status of lamin A/C in gastric cancer cell lines. 노세원, 노재경, 라선영, 오봉경, 이원석, 정재준, 정현철, 정희철
2012 Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer. 김남규, 라선영, 박찬희, 정현철
2012 A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer 형우진, 노성훈, 라선영, 안지영, 이성숙, 정현철, 정희철
2012 A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy. 라선영, 박경수, 신상준, 안중배, 이윤정, 정현철, 김혜련, 노재경
2012 A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. 노재경, 라선영, 신상준, 안중배, 정민규, 정현철, 정희철, 김혜련
2012 Phase II study of the safety and efficacy of temsirolimus in East Asian patients with advanced renal cell carcinoma 라선영
2012 Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group 노재경, 라선영, 정현철
2012 Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. 라선영
2012 Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes 라선영
2012 Body fluid MMP-2 as a putative biomarker in metastatic breast cancer 김기향, 노세원, 라선영, 이하영, 정민규, 정재준, 정희철
2012 Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy 김주항, 정현철, 라선영, 홍수정, 문용화, 박병우, 박세호, 손주혁, 구자승, 이수현, 김승일, 정민규
2012 Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy 금웅섭, 노성훈, 라선영, 안지영, 이용찬, 이창걸, 임준석, 형우진
2012 EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI 정민규, 조병철, 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준
2011 Brain metastases from colorectal carcinoma: prognostic factors and outcome 노재경, 라선영, 서창옥, 신상준, 안중배, 장종희, 정민규, 홍수정
2011 Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells 라선영, 장현, 정재준, 정현철, 정희철
2011 Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. 안중배, 양우익, 정현철, 정희철, 강승희, 김남규, 김한상, 노재경, 라선영, 민병소, 박찬희
2011 Prevalence and associated factors of psychological distress among Korean cancer patients 김건민, 김경란, 김승준, 남궁기, 라선영, 윤상현, 정현철
2011 Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases 김명진, 라선영, 박영년, 유선국, 최진영
2011 Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer 라선영, 안중배
2011 A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy 노성훈, 노재경, 라선영, 신상준, 안중배, 양우익, 임종근, 정현철, 정희철
2011 Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer 신상준, 정현철, 정희철, 노성훈, 노재경, 라선영
2011 A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis 노성훈, 라선영, 정현철, 정희철, 형우진, 김효송
2011 Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. 김기열, 김효송, 라선영, 신상준, 안중배, 정현철, 정희철, 홍민희
2011 CD44-SLC1A2 gene fusions in gastric cancer. 라선영, 정현철
2011 Treatment of recurrent hepatocellular carcinoma after liver transplantation 이수현, 이종두, 전성하, 전재윤, 정현철, 한광협, 김혜련, 라선영, 성진실
2011 Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer 정희철, 김효송, 노성훈, 노재경, 라선영, 박형순, 신상준, 전홍재, 정현철
2011 Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity 노재경, 라선영, 신규호, 신상준, 이영주, 정민규, 정재헌, 홍수정
2011 Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. 장준, 정민규, 조병철, 홍수정, 강영애, 김대준, 김세규, 김세현, 김주항, 라선영, 이영주
2011 Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy 노성훈, 라선영, 정재호
2011 Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis. 정현철, 정희철, 김효송, 남정모, 노성훈, 노재경, 라선영
2011 A densely interconnected genome-wide network of microRNAs and oncogenic pathways revealed using gene expression signatures 라선영, 정현철
2011 MMP-2 as a putative biomarker for carcinomatosis in gastric cancer 라선영, 박찬희, 정민규, 정재준, 정현철, 정희철, 노세원
2011 Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis 김남규, 김진수, 김혜련, 노재경, 라선영, 민병소, 신상준, 안중배
2011 Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. 라선영
2011 Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. 라선영
2011 Systematic analyses of genes associated with radiosensitizing effect by celecoxib, a specific cyclooxygenase-2 inhibitor 라선영, 신유근
2010 Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철
2010 Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철
2010 Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. 노성훈, 라선영, 임종근, 장현, 정현철, 정희철
2010 A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. 노성훈, 노재경, 라선영, 신상준, 안중배, 임종근, 정현철, 정희철
2010 Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells 라선영, 정희철, 장현, 정재준, 정현철
2010 The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites 노성훈, 라선영, 박준용, 이성숙, 이수현, 정민규, 정현철, 정희철, 홍수정
2010 Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer 정현철, 정희철, 천재희, 최혜진, 금기창, 김남규, 김호근, 노재경, 라선영, 백승혁, 신상준, 안중배, 임준석
2010 Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators 노재경, 라선영, 문용화, 신상준, 심효섭, 장현
2010 Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design 정희철, 홍민희, 김찬, 노성훈, 노재경, 라선영, 문용화, 장현, 정현철
2010 A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer 노재경, 라선영, 박경수, 신상준, 안중배, 정현철, 정희철
2010 Molecular characterization of alternative SET-NUP214 fusion transcripts in a case of acute undifferentiated leukemia. 김수정, 라선영, 송재우, 이경아, 이상국, 최종락
2010 Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression 노성훈, 노세원, 노재경, 라선영, 정민규, 정현철, 정희철
2010 Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray 정현철, 정희철, 강승희, 기동혁, 노성훈, 라선영, 이원석
2010 Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma 이성숙, 전성하, 정현철, 정희철, 라선영, 이광훈, 안정련, 김혜련, 노성훈
2010 Wernicke's encephalopathy in advanced gastric cancer 김건민, 김주훈, 라선영, 윤상현, 이수현, 정은석, 정희철
2010 Green tea consumption and stomach cancer risk: a meta-analysis. 남정모, 라선영
2010 The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up 김효송, 노재경, 라선영, 문용화, 신현준, 양우익, 정민규, 정현철, 정희철, 홍수정
2010 Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis. 김건민, 김기향, 김주훈, 김효송, 라선영, 박영년, 윤상현, 최준정
2010 Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites 김기향, 김민재, 김주훈, 김찬, 김효송, 노재경, 라선영, 안중배, 윤상현, 정현철, 김건민
2010 Kidney Cancer Working Group report. 라선영
2009 In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer 김용태, 노성훈, 라선영, 이정옥, 정현철, 정희철
2009 Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients 권우선, 노재경, 라선영, 안중배, 유내춘, 임종근, 장현, 정현철, 정희철
2009 Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials 안중배, 정현철, 정희철, 노성훈, 노재경, 라선영, 박찬희, 신상준
2009 G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern 권우선, 노성훈, 라선영, 안중배, 정재준, 정현철, 정희철
2009 The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer 오성진, 정현철, 최승호, 형우진, 강욱호, 노성훈, 라선영, 송재원
2009 Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma 노성훈, 라선영, 송재원, 오성진, 정현철, 최승호, 형우진
2009 Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery. 라선영, 양우익, 정현철, 정희철
2009 Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer 임종근, 정현철, 정희철, 노성훈, 노재경, 라선영, 신상준, 안중배
2009 Subtelomeric DNA methylation and telomere length in human cancer cells 라선영, 정현철, 정희철
2009 Prediction of recurrence of early gastric cancer after curative resection 김기열, 김성수, 노성훈, 라선영, 오성진, 이찬주, 정현철, 최승호
2009 Identification of significant regional genetic variations using continuous CNV values in aCGH data 김기열, 김진, 라선영, 이귀연, 정현철, 정희철
2009 A weighted sample size for microarray datasets that considers the variability of variance and multiplicity. 김기열, 라선영, 정현철
2009 Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. 라선영
2009 DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers 라선영
2009 Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. 라선영
2009 Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. 라선영
2009 Oncogenic pathway combinations predict clinical prognosis in gastric cancer 라선영, 정현철
2009 Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea 신상준, 안정련, 안중배, 전홍재, 정현철, 홍민희, 김찬, 김효송, 라선영
2009 Prognosis of pN3 stage gastric cancer 형우진, 홍민희, 김찬, 김혜련, 노성훈, 라선영, 안정련, 이성숙, 전홍재, 정민규, 정현철, 정희철
2009 Clinical value of ezrin expression in primary osteosarcoma 김찬, 김혜련, 노재경, 라선영, 안중배, 양우익, 전홍재, 홍민희, 홍수정
2009 Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma 김혜련, 노재경, 라선영, 박영년, 유내춘, 전성하
2009 Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer 문용화, 양우익, 유내춘, 정재헌, 정현철, 정희철, 권오빈, 라선영
2009 A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status 노성훈, 노재경, 라선영, 이수현, 정재헌, 정현철, 정희철
2009 Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials. 김찬, 김혜련, 노성훈, 라선영, 안정련, 임종근, 전홍재, 정현철, 정희철, 홍민희
2009 Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. 정현철, 정희철, 라선영
2009 Prognostic index reflecting genetic alteration related to disease-free time for gastric cancer patient 라선영
2009 Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction 라선영, 박세미, 신상준, 안중배, 이상길, 정현철, 정희철
2008 Variation of the 3' telomeric overhang lengths in human cells 라선영, 오봉경, 정현철, 정희철
2008 Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer 라선영, 정현철
2008 Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer 전성하, 정현철, 정희철, 천재희, 최혜진, 금기창, 김남규, 노재경, 라선영, 백승혁, 신상준, 안중배
2008 Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철, 조병철, 노재경, 최혜진
2008 The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer 안중배, 정현철, 정희철, 조병철, 최혜진, 노재경, 라선영, 신상준
2008 A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. 노성훈, 노재경, 라선영, 유내춘, 임종근, 정현철, 정희철
2008 Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up. 노성훈, 노재경, 라선영, 문용화, 민진식, 유내춘, 정현철, 정희철
2008 Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases 노성훈, 노재경, 라선영, 안중배, 임종근, 전성하, 정현철, 정희철
2008 Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions 김기열, 라선영, 정현철, 정희철
2008 Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene 라선영, 정현철
2008 OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation 라선영
2008 SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis. 라선영
2008 S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer 노성훈, 라선영, 안중배, 양우익, 정종열, 정현철, 정희철
2008 Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma. 유은정, 정현철, 정희철, 노성훈, 라선영, 양우익, 오봉경
2008 Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer 김남규, 김호근, 라선영, 민병소, 성진실, 정현철
2008 Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer 노성훈, 노재경, 라선영, 신상준, 임종근, 정현철, 정희철
2008 Disease Prediction Using Ranks of Gene Expressions 정현철, 김기열, 라선영
2008 Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer 노재경, 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철, 노성훈
2007 Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy 김세현, 노재경, 라선영, 신상준, 안중배, 이혜원, 정현철, 정희철, 조병철, 최혜진
2007 Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute 정희철, 김병수, 노성훈, 노재경, 라선영, 문용화, 유내춘, 정현철
2007 Molecular basis of the differences between normal and tumor tissues of gastric cancer 노성훈, 라선영, 신지혜, 양상화, 양우익, 정현철, 정희철
2007 Novel and simple transformation algorithm for combining microarray data sets 기동혁, 김기열, 라선영, 정하진, 정현철, 정희철
2007 Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization 정희철, 라선영, 양우익, 이귀연, 정현철
2007 Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer 최연호, 라선영, 양우익, 정현철
2007 A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철
2007 Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) 라선영, 정현철, 정희철, 노재경
2007 A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer 라선영, 정현철, 정희철, 노성훈, 노재경
2007 An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions 김기열, 김세현, 라선영, 정재헌, 정하진, 정현철, 정희철, 기동혁
2007 A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and ... 김세현, 라선영, 안중배, 정재헌, 정현철, 정희철, 조남훈
2007 Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer 라선영, 양상화, 양우익, 정하진, 정현철, 정희철, 최연호
2007 Whole genome analysis for liver metastasis gene signatures in colorectal cancer 기동혁, 김남규, 라선영, 박찬희, 이귀연, 이원석, 정현철, 정희철
2007 Integrated in silico and biological validation of the blocking effect of C(o)t-1 DNA on microarray-CGH 김기열, 라선영, 정현철, 정희철
2007 Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNA 라선영, 양상화, 정현철
2007 A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation 성진실, 정현철, 표홍렬, 금기창, 김남규, 김호근, 라선영, 민병소, 백승혁
2007 Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters 노재경, 라선영, 양우익, 정현철
2007 Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single Institute 노성훈, 라선영, 정재호, 정현철, 정희철, 조병철, 최혜진, 형우진
2007 The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas 라선영
2007 The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation 라선영
2007 Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations 노성훈, 라선영, 박찬희, 안중배, 정현철, 정희철
2007 An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients 정현철, 정희철, 최연호, 노재경, 라선영, 양우익
2007 Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma 김도영, 김자경, 라선영, 안상훈, 윤기태, 윤미진, 이종두, 전재윤, 한광협
2007 Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents 라선영, 정현철, 정희철
2007 Gastrointestinal stromal tumor of the rectum: An analysis of seven cases 김남규, 김호근, 라선영, 백승혁, 손승국, 이강영, 정현철, 조장환
2007 Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia 라선영, 유철주
2006 Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA 라선영, 조남훈, 조상호
2006 Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression 라선영, 정현철
2006 Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer 라선영, 안성환, 양우익, 정현철, 정희철
2006 유방암의 전신적 재발로 오인된 톡소플라스마증 1예 김범경, 라선영, 이용원, 정현수, 정현철, 정희철, 조병철
2006 Intermediate Dose 5-Fluorouracil-Induced Encephalopathy 라선영, 성진실, 정현철, 정희철
2006 A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer 노성훈, 노재경, 라선영, 정현철, 정희철
2006 A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens 노재경, 라선영, 안중배, 유내춘, 정현철, 정희철
2004 Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas 김귀언, 김주항, 노재경, 라선영, 서창옥, 양우익, 유내춘, 이상욱, 정현철, 조재호, 한지숙
2004 Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines 라선영, 정현철
2004 The pattern of gene copy number changes in bilateral breast cancer surveyed by cDNA microarray-based comparative genomic hybridization. 라선영, 박병우, 박찬희, 서민영, 안중배, 양상화, 양우익, 이귀연, 정현철
2004 Statistical methods of determining a cut off value between normal and disease groups 라선영, 정현철
2003 cDNA Microarray Experiment: Design Issues in Early Stage and the Need of Normalization 라선영, 정현철
2003 Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray 라선영, 양상화, 정현철
2003 Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer 라선영, 정현철
2003 Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer 노재경, 라선영, 손주혁
2003 Infusional Fluorouracil, Etoposide, and Cisplatin (FEP) in Advanced and Relapsed Gastric Cancer 손주혁, 정현철, 정희철, 노성훈, 라선영
2003 Paclitaxel and Cisplatin Combination Chemotherapy in Pretreated Breast Cancer 라선영, 손주혁
2003 A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma 라선영, 손주혁, 심지영, 유내춘, 정현철, 한대석, 김용태, 김주항, 김철, 노재경
2003 Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma 강숙희, 라선영, 심효섭, 조남훈, 조상호, 최영득, 홍성준, 홍성희
2002 Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. 노성훈, 라선영, 정현철, 정희철
2002 동소이식을 이용한 위암의 전이모델. 노성훈, 노재경, 라선영, 형우진
2002 A phase II study of gemcitiabine monotherapy in breast cancer patients refractory to anthracycline and taxane 라선영, 정현철
2002 Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell. 김준명, 라선영, 정현철
2002 Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. 노성훈, 라선영, 정현철, 정희철
2002 cDNA microarray를 이용한 HPV-16 E6와 연관된 유전자의 발현 분석 라선영
2001 Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects 라선영
2001 Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities 신규호, 신현준, 양우익, 정현철, 정희철, 한수봉, 노재경, 라선영, 민진식, 손주혁, 구영석
2001 Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer 노재경, 라선영, 안중배, 정현철, 정희철
2001 Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. 노성훈, 라선영, 정현철, 정희철